Dimalig, Kyllr .

HRN: 25-36-47  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2026
CEFUROXIME 750MG (VIAL)
05/02/2026
05/09/2026
IVTT
750mg
Q8h
UTI
Pending Pharmacy Acceptance 

 Indication:  Culture-directed    Type of Infection:  Urinary Tract    Compliance to guidelines: